Gennex Laboratories: Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025

In just concluded Meeting of Board of Directors the Board Approved and considered the following items:1. Unaudited (Standalone and Consolidated) Financial Statements for the Quarter and Half year ended September 30 2025 (annexed herewith); 2. Limited review reports from the Statutory Auditor on Unaudited (Standalone and Consolidated) Financial Statements for the Quarter and Half year ended September 30 2025 (annexed here with);3. Other Business items. We hereby submit that the Board Meeting had commenced at 04:00 PM and concluded at 5:00 PM.This intimation is also uploaded on the Company website: www.gennexlab.com. We request you to take the above information on record and acknowledge the receipt of the same.